• Gastroesophageal reflux disease and proton pump inhibitors. PPIs have played a significant role in reducing refractory esophageal strictures resulting from GERD, as well as mitigating upper GI disease complications in general.
• Colorectal cancer screening. Over the past 20 years, colonoscopy has become the gold standard for colorectal cancer screening. Additionally, new technologies have joined the ranks of CRC screening options.
• Hepatitis C treatment. New treatments for HCV are effective, with significantly reduced side effects.
• Fecal microbiota transplantation. FMT has demonstrated efficacy in treating refractory Clostridium difficile infection.
More articles on gastroenterology:
3 GI physicians making headlines – June 19, 2015
Keeping up with quality reporting in GI: 2 gastroenterologists weigh in
ASGE names Dr. Douglas Faigel president: 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.